• Oasmia launches the ovarian cancer treatment drug Apealea® in Sweden, Denmark and Finland

  • Oasmia and Elevar sign a global strategic partnership for the commercialization of Apealea®

  • Year-end Report 2019 / 2020

  • Analysguiden: Interview with Oasmia

    30 juli, 2020

The Share